In line with these observations, TOP2 inhibition with Etoposide treatment significantly impaired GBM cell migration in wound-healing assays (Figure 2G), supporting its potential to inhibit both proliferative and invasive tumor behaviors. This evidence concerns the gene TOP2A and neoplasm.